France Sarcopenia Market (2025-2031) | Value, Share, Forecast, Growth, Analysis, Trends, Industry, Companies, Segmentation, Size & Revenue, Outlook, Competitive Landscape

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 France Country Macro Economic Indicators

3.2 France Sarcopenia Market Revenues & Volume, 2021 & 2031F

3.3 France Sarcopenia Market - Industry Life Cycle

3.4 France Sarcopenia Market - Porter's Five Forces

3.5 France Sarcopenia Market Revenues & Volume Share, By Supplement Type, 2021 & 2031F

3.6 France Sarcopenia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in France

4.2.2 Growing awareness about sarcopenia and its impact on health

4.2.3 Rising prevalence of chronic diseases leading to sarcopenia

4.3 Market Restraints

4.3.1 Limited availability of specialized healthcare facilities for sarcopenia treatment in France

4.3.2 High cost of diagnostic tests and treatment for sarcopenia

6.1 France Sarcopenia Market, By Supplement Type

6.1.1 Overview and Analysis

6.1.2 France Sarcopenia Market Revenues & Volume, By Supplement Type, 2021- 2031F

6.1.3 France Sarcopenia Market Revenues & Volume, By Protein Supplement, 2021- 2031F

6.1.4 France Sarcopenia Market Revenues & Volume, By Vitamin D & Calcium Supplement, 2021- 2031F

6.1.5 France Sarcopenia Market Revenues & Volume, By Vitamin B12 Supplement, 2021- 2031F

6.2 France Sarcopenia Market, By Distribution Channel

6.2.1 Overview and Analysis

6.2.2 France Sarcopenia Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.2.3 France Sarcopenia Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.2.4 France Sarcopenia Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.2.5 France Sarcopenia Market Revenues & Volume, By Hypermarket & Supermarket, 2021- 2031F

7.1 France Sarcopenia Market Export to Major Countries

7.2 France Sarcopenia Market Imports from Major Countries

8.1 Percentage increase in the number of geriatric patients being screened for sarcopenia annually

8.2 Adoption rate of new sarcopenia treatment guidelines by healthcare providers in France

8.3 Number of research studies conducted on sarcopenia in France

8.4 Average waiting time for patients seeking diagnostic tests for sarcopenia

8.5 Patient satisfaction scores related to sarcopenia treatment and care services provided

9.1 France Sarcopenia Market Opportunity Assessment, By Supplement Type, 2021 & 2031F

9.2 France Sarcopenia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 France Sarcopenia Market Revenue Share, By Companies, 2024

10.2 France Sarcopenia Market Competitive Benchmarking, By Operating and Technical Parameters